Abstract:Bone sarcomas, which comprise less than 1% of all human malignancies, are a group of relatively rare mesenchymal-derived tumors. They are mainly composed of osteosarcoma, chondrosarcoma and Ewing's sarcoma. In spite of advances in adjuvant chemotherapy and wide surgical resection, prognosis remains poor due to the high propensity for lung metastasis, which is the leading cause of mortality in patients with bone sarcomas. Chemokines are a superfamily of small pro-inflammatory chemoattractant cytokines which can bind to specific G protein-coupled seven-span transmembrane receptors. Chemokine 12 (CXCL12), also designated as stromal cell-derived factor-1 (SDF-1), is able to bind to its cognate receptors, chemokine receptor 4 (CXCR4) and chemokine receptor 7 (CXCR7), with high affinity. The binding of CXCL12 to CXCR4/CXCR7 stimulates the activation of several downstream signaling pathways that regulate tumor progression and metastasis. In this review, the structure and function of CXCL12 and its receptors, CXCR4 and CXCR7, as well as many factors affecting their expression are discussed. Phosphoinositide 3-kinase (PI3K) and mitogen-activated protein kinase (MAPK) pathways are the two most important downstream pathways regulated by the CXCL12-CXCR4/CXCR7 interaction. CXCR4 expression in bone sarcomas, including tumor cells and samples and the correlation between CXCR4/CXCR7 expression and the survival of patients with bone sarcomas are also discussed. In addition, we review the involvement of the CXCL12‑CXCR4/CXCR7 axis in the growth and metastasis of bone sarcomas and the targeting of this axis in preclinical studies.

Chemokines in bone-metastatic breast cancer: Therapeutic opportunities

Chemokines: Function and therapeutic potential in bone metastasis of lung cancer

Chemokines and chemokine receptors: A new strategy for breast cancer therapy

Targeting the Wnt signaling pathway for breast cancer bone metastasis therapy

The relationship between chemokines and breast cancer

Advances in Research on the Effects and Mechanisms of Chemokines and Their Receptors in Cancer

Immunotherapy in the Fight Against Bone Metastases: A Review of Recent Developments and Challenges

Role of Tumor-Derived Chemokines in Osteolytic Bone Metastasis

Progress and Challenge in Development of Biotherapeutics Targeting MET Receptor for Treatment of Advanced Cancer.

Beyond boundaries: unraveling innovative approaches to combat bone-metastatic cancers

Multiple influence of immune cells in the bone metastatic cancer microenvironment on tumors

Advancing Treatment of Bone Metastases through Novel Translational Approaches Targeting the Bone Microenvironment

The role of the CXCL12-CXCR4/CXCR7 axis in the progression and metastasis of bone sarcomas (Review).

Chemokine-Directed Tumor Microenvironment Modulation in Cancer Immunotherapy

Tumor-Stroma Interactions in Bone Metastasis: Molecular Mechanisms and Therapeutic Implications.

The Potential Therapeutic Targets to Bone Pain Induced by Cancer Metastasis

Novel approaches to target the microenvironment of bone metastasis

Chemokine receptors and their ligands in breast cancer: The key roles in progression and metastasis

Chemokines and Chemokine Receptors: New Targets for Cancer Immunotherapy

Chemokines and their role in tumor growth and metastasis

Wnt signaling in bone metastasis: mechanisms and therapeutic opportunities